Evidence map›Paper›PMID 41150057›Full record

ArticleMicrobial genomics2025

Whole-genome analysis of rotavirus G1P[8] and other Wa-like strains in Mozambican children: evidence of genetic variations of pre-vaccine G1P[8] strains from Manhiça, Mozambique.

Filomena Manjate, Percina Chirinda, Peter Mwangi, Eva D João, Milton Mogotsi, Marcelino Garrine, Augusto Messa Jr, Delfino Vubil, Nélio Nobela, Karen Kotloff and 11 more

Abstract read
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Filomena ManjateCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Percina ChirindaCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Peter MwangiNext Generation Sequencing Unit, School of Biomedical Sciences and Division of Virology, Faculty of Health Sciences, University of Free State, Bloemfontein, South Africa.
Eva D JoãoCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Milton MogotsiNext Generation Sequencing Unit, School of Biomedical Sciences and Division of Virology, Faculty of Health Sciences, University of Free State, Bloemfontein, South Africa.
Marcelino GarrineCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Augusto Messa JrCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Delfino VubilCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Nélio NobelaCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Karen KotloffCenter for Vaccine Development (CVD), University of Maryland, School of Medicine, Baltimore, MD 21201, USA.
James P NataroDepartment of Paediatrics, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
Tacilta NhampossaCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Sozinho AcácioCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Goitom WeldegebrielAfrican Rotavirus Surveillance Network, Immunization, Vaccines and Development Program, World Health Organization, Regional Office for Africa, Brazzaville P.O. Box 2465, Republic of Congo.
Jacqueline E TateCenters for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA.
Umesh ParasharCenters for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA.
Jason M MwendaAfrican Rotavirus Surveillance Network, Immunization, Vaccines and Development Program, World Health Organization, Regional Office for Africa, Brazzaville P.O. Box 2465, Republic of Congo.
Pedro L AlonsoCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.
Martin NyagaNext Generation Sequencing Unit, School of Biomedical Sciences and Division of Virology, Faculty of Health Sciences, University of Free State, Bloemfontein, South Africa.
Celso CunhaGlobal Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), 1349-008 Lisbon, Portugal.
Inácio MandomandoCentro de Investigação em Saúde de Manhiça (CISM), Maputo 1929, Mozambique.

Funding

VTEU SupplementUM1AI148689 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Karen L. Kotloff · 2020 to 2026
$52.7M
NIAID NIH HHS UM1 AI148689World Health Organization 001
6 · The paper itself

Abstract

The Rotarix® (GlaxoSmithKline, Rixenstart, Belgium) vaccine was adopted into the Expanded Program on Immunization in Mozambique in September 2015, and G1P[8] strains were frequent pre- and post-vaccine introduction in some regions of the country. In the current study, G1P[8] and other strains (G12P[6], G12P[8] and G9P[8]) circulating between 2008-2012 and 2015 in children with and without diarrhoea were characterized by next-generation sequencing to understand their genetic composition. The G1P[8] strains were compared with Mozambican pre- and post-vaccine strains retrieved from GenBank. All study strains, either from children with or without diarrhoea, were genetically similar and exhibited a typical Wa-like constellation. The Mozambican pre- and post-vaccine G1 strains clustered in two separate lineages: most pre-vaccine strains in lineage I and all post-vaccine strains in lineage II. Meanwhile, all P[8] were in lineage III, although the study strains were in a different cluster from the G1P[8] post-vaccine strains retrieved in GenBank. Analysis of VP7 epitope regions showed amino acid differences such as S123N and M217T in all study strains, while a change N94S was observed in seven strains and K291R in eight strains. Sequence alignment of G1P[8] study strains using mVISTA confirmed that they may have suffered point mutations in all their 11 segments. Our results suggest that host factors are implicated in the inducement and severity of diarrhoea and these factors need further investigation. The changes in some G1 strains at the epitope region emphasize the need for continued whole-genome analysis, as substitutions in this region are reported to affect protein conformation at given positions and the study results may provide data for future studies aiming to understand rotavirus strain evolution post-vaccine introduction.

Indexed as

Genetic VariationRotavirusRotavirus InfectionsCapsid ProteinsChild, PreschoolDiarrheaGenome, ViralHigh-Throughput Nucleotide SequencingHumansInfantMozambiquePhylogenyRotavirus VaccinesVaccines, AttenuatedWhole Genome SequencingCapsid ProteinsRIX4414 vaccineRotavirus VaccinesVaccines, Attenuatedlineagesrotavirus in MozambiqueWa-like constellationwhole-genome sequencing

Identifiers

PMID41150057
PMCPMC12562872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.